WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 14.217 ↑ 0.68%
[as on 20 October, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 3.13% 0.68% 1.25% 0.52% 2.61% 8.51%----

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
89.10% 4.78% (Arbitrage: 0.00%) 0.00% 0.00% 6.12%

Equity

NameSectorWeight %
JB Chemicals & Pharmaceuticals LimitedPharmaceuticals & Biotechnology6.94%
Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology6.81%
Fortis Healthcare LimitedHealthcare Services6.69%
Cipla LimitedPharmaceuticals & Biotechnology4.56%
Laurus Labs LimitedPharmaceuticals & Biotechnology4.28%
Krishna Institute Of Medical Sciences LimitedHealthcare Services4.09%
Neuland Laboratories LimitedPharmaceuticals & Biotechnology3.20%
Max Healthcare Institute LimitedHealthcare Services3.19%
Lupin LimitedPharmaceuticals & Biotechnology3.14%
Apollo Hospitals Enterprise LimitedHealthcare Services3.05%
Sai Life Sciences LimitedPharmaceuticals & Biotechnology2.89%
Divi's Laboratories LimitedPharmaceuticals & Biotechnology2.77%
Vijaya Diagnostic Centre LimitedHealthcare Services2.48%
Abbott India LimitedPharmaceuticals & Biotechnology2.14%
Gland Pharma LimitedPharmaceuticals & Biotechnology1.94%
Shaily Engineering Plastics LimitedIndustrial Products1.91%
Ajanta Pharma LimitedPharmaceuticals & Biotechnology1.75%
Jupiter Life Line Hospitals LimitedHealthcare Services1.66%
Kovai Medical Center and Hospital LimitedHealthcare Services1.65%
Mankind Pharma LimitedPharmaceuticals & Biotechnology1.64%
Glenmark Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.61%
GlaxoSmithKline Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.58%
Anthem Biosciences LimitedPharmaceuticals & Biotechnology1.51%
Pfizer LimitedPharmaceuticals & Biotechnology1.50%
AstraZeneca Pharma India LimitedPharmaceuticals & Biotechnology1.48%
Alembic Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.40%
Emcure Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.36%
Eris Lifesciences LimitedPharmaceuticals & Biotechnology1.19%
Thyrocare Technologies LimitedHealthcare Services1.19%
Poly Medicure LimitedHealthcare Equipment & Supplies1.03%
Acutaas Chemicals LimitedPharmaceuticals & Biotechnology0.94%
Healthcare Global Enterprises LimitedHealthcare Services0.80%
Dr.Agarwals Eye Hospital LimitedHealthcare Services0.79%
Supriya Lifescience LimitedPharmaceuticals & Biotechnology0.79%
Navin Fluorine International LimitedChemicals & Petrochemicals0.75%
Shilpa Medicare LimitedPharmaceuticals & Biotechnology0.70%
Aster DM Healthcare LimitedHealthcare Services0.58%
Zota Health Care LimitedPharmaceuticals & Biotechnology0.56%
Piramal Pharma LimitedPharmaceuticals & Biotechnology0.51%
PB Fintech LimitedFinancial Technology (Fintech)0.50%
Jubilant Ingrevia LimitedChemicals & Petrochemicals0.46%
Orchid Pharma LimitedPharmaceuticals & Biotechnology0.45%
Onesource Specialty Pharma LimitedPharmaceuticals & Biotechnology0.42%
Laxmi Dental LimitedHealthcare Equipment & Supplies0.22%

Debt

NameRatingWeight %
91 Days Tbill (MD 02/10/2025)Sovereign1.13%
364 Days Tbill (MD 18/12/2025)Sovereign1.12%
182 Days Tbill (MD 25/12/2025)Sovereign0.67%
364 Days Tbill (MD 03/10/2025)Sovereign0.45%
91 Days Tbill (MD 04/12/2025)Sovereign0.45%
91 Days Tbill (MD 30/10/2025)Sovereign0.27%
91 Days Tbill (MD 20/11/2025)Sovereign0.22%
91 Days Tbill (MD 28/11/2025)Sovereign0.22%
91 Days Tbill (MD 16/10/2025)Sovereign0.11%
182 Days Tbill (MD 23/10/2025)Sovereign0.09%
91 Days Tbill (MD 23/10/2025)Sovereign0.05%
Portfolio data is as on date 30 September, 2025

NAV (Net asset value) history

WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth - 30 days NAV history

DateNAV
20 October, 202514.217
17 October, 202514.121
16 October, 202514.054
15 October, 202513.976
14 October, 202513.950
13 October, 202514.042
10 October, 202514.032
9 October, 202513.901
8 October, 202513.808
7 October, 202513.851
6 October, 202513.808
3 October, 202513.675
1 October, 202513.698
30 September, 202513.522
29 September, 202513.539
26 September, 202513.495
25 September, 202513.802
24 September, 202513.886
23 September, 202513.955
22 September, 202514.006
19 September, 202514.143
18 September, 202514.141
17 September, 202514.080
16 September, 202514.065
15 September, 202514.030
12 September, 202514.088
11 September, 202514.074
10 September, 202514.039
9 September, 202513.985
8 September, 202513.924

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth?
    The latest NAV of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth is 14.217 as on 20 October, 2025.
  • What are YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth?
    The YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth are 3.13% as on 20 October, 2025.
  • What are 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth?
    The 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth are 8.51% as on 20 October, 2025.